Examining the implications of the recent US executive orders concerning diversity, equity, and inclusion pursuits—and the key ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

The following is a summary of “Community Leaders’ Perceptions of Pain and Research Engagement: Implications for Participant Diversity and Inclusion in Pain Clinical Trials,” published in the April ...

Groundbreaking research has profoundly impacted neurology and benefited patients with neurodegenerative diseases. However, a closer look at the authorship is necessary to understand the impact of ...

In this video interview, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA), discusses numerous themes that clin ops can focus on to keep its trials running efficiently and ...

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

Top-down proteomics: Intact proteins are ionized and analyzed directly, allowing for the study of proteoforms and ...

Clinical research continues to struggle with a lack of representation within trial populations, and gender diversity in clinical trials remains a critical issue. The theme for this year’s ...

The United States once led the world in running clinical trials that aimed to look like the nation at large. Now it is ...

The American Civil Liberties Union also filed a lawsuit last week, alleging that the federal agency and its parent department ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...